Back to search
BE

BE · BE · BE-AMP-SAM462631-00

Incruse Ellipta 55 µg

ATC R03BB07

Last synced from FAMHP / AFMPS (Belgium) on

Identification

ManufacturerGlaxoSmithKline Trading Services
CountryBE (BE)
ATC codeR03BB07
Dispensing
ReimbursedNo
SourceFAMHP / AFMPS (Belgium)
Last synced6/13/2026

Packs · 3

  • be_apb
    3270402
  • be_apb
    7712862
  • be_apb
    3270410

Annotations

No annotations yet.

Raw payload (JSON)
{
  "form": "Inhalation powder, pre-dispensed",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Incruse Ellipta 55 µg",
  "name_fr": "Incruse Ellipta 55 µg",
  "name_nl": "Incruse Ellipta 55 µg",
  "amp_code": "SAM462631-00",
  "strengths": [
    "65.0000",
    "65.0000",
    "55.0000",
    "55.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Umeclidinium Bromide",
    "Umeclidinium"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Umeclidinium Bromide",
  "authorisation_numbers": [
    "EU/1/14/922/001",
    "EU/1/14/922/002",
    "EU/1/14/922/003"
  ]
}

Related drugs

Other records sharing ATC code R03BB07.

Access this data programmatically

Query Incruse Ellipta 55 µg and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.